TipRanks
Altamira Therapeutics (CYTOF)
OTHER OTC:CYTOF
US Market
CYTOF
Altamira Therapeutics
RESEARCH TOOLSreports
Want to see CYTOF full AI Analyst Report?

Altamira Therapeutics (CYTOF) Revenue

599 Followers
StatisticsRevenue

Altamira Therapeutics Revenue

Altamira Therapeutics had a revenue of 52.73K in the quarter ending Jun 30, 2023, with 0.00%. This bring the company's revenue in the last twelve months to -353.22K, Increased -35.56%. In the fiscal year ending Dec 31, 2023, Altamira Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
-353.22K
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
$0
Employees
12
Market Cap
$409.23K

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023
―-305.62K-100.00%
Dec 31, 2022
305.62K241.73K+378.41%
Dec 31, 2021
63.88K-110.59K-63.39%
Dec 31, 2020
174.47K230.47K-411.56%
Dec 31, 2019
-56.00K-1.32M-104.42%
Dec 31, 2018
1.27M――